People · Operator
Named in public records as an officer, director or promoter · active 2018–2023 · Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cala Health, Inc. | — | Healthtech | Series C | $166.1M | $370.1M | 2018 |
| OncoResponse Inc | — | Biotechnology | Series C | $109.0M | $39.4M | 2023 |
Ted A. Koutouzis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ted A. Koutouzis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven Gillis | 1 | 23 |
| Wende Hutton | 1 | 16 |
| Andrew Perlman | 1 | 15 |
| Steve Gillis | 1 | 13 |
| Geeta Vemuri | 1 | 7 |
| Michael Carusi | 1 | 7 |
| Michael A. Carusi | 1 | 6 |
| Renee Ryan | 1 | 6 |
| John McKearn | 1 | 6 |
| John Kuelper | 1 | 6 |
| Juan-Pablo Mas | 1 | 5 |
| James Lee | 1 | 5 |
| Clifford Stocks | 1 | 5 |
| STACY ENXING SENG | 1 | 5 |
| Nicole Walker | 1 | 4 |
| NEIL TIWARI | 1 | 4 |
| ROBERT PAULL | 1 | 4 |
| TED KOUTOUZIS | 1 | 4 |
| MARK A. DEEM | 1 | 3 |
| ASHA NAYAK | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.